Emerging role of relaxin in renal and cardiovascular function
- 1 August 2004
- journal article
- review article
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 287 (2) , R250-R261
- https://doi.org/10.1152/ajpregu.00672.2003
Abstract
Although traditionally associated with reproductive processes, relaxin is emerging as an important player in renal and cardiovascular function. Much of our recently acquired understanding of relaxin in this new context has arisen from studies of maternal renal and cardiovascular adaptations to pregnancy in rats where the hormone is turning out to be an important mediator. First, we highlight the influence of relaxin on renal hemodynamics and glomerular filtration rate, as well as on other peripheral circulations. Second, we discuss the effect of relaxin on both the steady and pulsatile systemic arterial load, as well as on the heart, in particular, coronary blood flow. Third, we consider the impact of the hormone on cultured endothelial and vascular smooth muscle cells. Fourth, we address the interaction of relaxin with renal and cardiac disease, as well as its role in angiogenesis. Finally, in Perspectives, we point out several key research questions in need of investigation that relate to a potential autocrine/paracrine role of relaxin in renal and cardiovascular tissues. Furthermore, on the basis of its potent vasodilatory and matrix-degrading attributes, we speculate about the therapeutic potential of relaxin in renal and cardiovascular diseases.Keywords
This publication has 105 references indexed in Scilit:
- Relaxin up‐regulates inducible nitric oxide synthase expression and nitric oxide generation in rat coronary endothelial cellsThe FASEB Journal, 2001
- Flow-Induced Pressure Differentially Regulates Endothelin-1, Urotensin II, Adrenomedullin, and Relaxin in Pulmonary Vascular EndotheliumBiochemical and Biophysical Research Communications, 2001
- In Vivo Localization of Gelatinases (MMP-2 and -9) by in Situ Zymography with a Selective Gelatinase InhibitorBiochemical and Biophysical Research Communications, 2001
- Relaxin decreases renal interstitial fibrosis and slows progression of renal diseaseKidney International, 2001
- MMP-2 Colocalizes with Caveolae on the Surface of Endothelial CellsExperimental Cell Research, 2001
- Relaxin, a Potent Microcirculatory Effector, Is Not AngiogenicInternational Journal of Microcirculation, 1996
- Pressure Enhances Endothelin-1 Release From Cultured Human Endothelial CellsHypertension, 1995
- A single-copy relaxin-like gene sequence is present in sheepMolecular and Cellular Endocrinology, 1993
- Phosphoramidon Blocks the Pressor Activity of Big Endothelin[1–39] and Lowers Blood Pressure in Spontaneously Hypertensive RatsJournal of Cardiovascular Pharmacology, 1991
- Effect of four primary prostaglandins and relaxin on blood flow in the ovine endometrium and myometriumBiology of Reproduction, 1984